Correlation Between Allarity Therapeutics and InMed Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Allarity Therapeutics and InMed Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allarity Therapeutics and InMed Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allarity Therapeutics and InMed Pharmaceuticals, you can compare the effects of market volatilities on Allarity Therapeutics and InMed Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allarity Therapeutics with a short position of InMed Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allarity Therapeutics and InMed Pharmaceuticals.

Diversification Opportunities for Allarity Therapeutics and InMed Pharmaceuticals

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Allarity and InMed is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Allarity Therapeutics and InMed Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on InMed Pharmaceuticals and Allarity Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allarity Therapeutics are associated (or correlated) with InMed Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of InMed Pharmaceuticals has no effect on the direction of Allarity Therapeutics i.e., Allarity Therapeutics and InMed Pharmaceuticals go up and down completely randomly.

Pair Corralation between Allarity Therapeutics and InMed Pharmaceuticals

Given the investment horizon of 90 days Allarity Therapeutics is expected to generate 0.54 times more return on investment than InMed Pharmaceuticals. However, Allarity Therapeutics is 1.85 times less risky than InMed Pharmaceuticals. It trades about -0.18 of its potential returns per unit of risk. InMed Pharmaceuticals is currently generating about -0.27 per unit of risk. If you would invest  151.00  in Allarity Therapeutics on August 27, 2024 and sell it today you would lose (23.00) from holding Allarity Therapeutics or give up 15.23% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Allarity Therapeutics  vs.  InMed Pharmaceuticals

 Performance 
       Timeline  
Allarity Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Allarity Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's essential indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
InMed Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days InMed Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Allarity Therapeutics and InMed Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Allarity Therapeutics and InMed Pharmaceuticals

The main advantage of trading using opposite Allarity Therapeutics and InMed Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allarity Therapeutics position performs unexpectedly, InMed Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InMed Pharmaceuticals will offset losses from the drop in InMed Pharmaceuticals' long position.
The idea behind Allarity Therapeutics and InMed Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories